FABP3 and myocardial infarction: This has necessitated the search for novel biomarkers to rule in and rule out myocardial MI in chest pain patients early, the most notable being the heart-type fatty acid binding protein (h-FABP); however, studies on h-FABP as a reliable marker for MI diagnosis have been largely disappointing [16].